These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23274668)

  • 1. Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.
    Hamasaki T; Okamoto M; Baba M
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1323-31. PubMed ID: 23274668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Tat-TAR RNA Interaction for HIV-1 Inhibition.
    Alanazi A; Ivanov A; Kumari N; Lin X; Wang S; Kovalskyy D; Nekhai S
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
    Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
    Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
    Richter S; Cao H; Rana TM
    Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.
    Lalonde MS; Lobritz MA; Ratcliff A; Chamanian M; Athanassiou Z; Tyagi M; Wong J; Robinson JA; Karn J; Varani G; Arts EJ
    PLoS Pathog; 2011 May; 7(5):e1002038. PubMed ID: 21625572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive activity between the trans-activation response RNA-binding protein, TRBP2, and cyclin T1 on HIV type 1 expression and viral production in murine cells.
    Battisti PL; Daher A; Bannwarth S; Voortman J; Peden KW; Hiscott J; Mouland AJ; Benarous R; Gatignol A
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):767-78. PubMed ID: 14585207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1.
    Zhang J; Tamilarasu N; Hwang S; Garber ME; Huq I; Jones KA; Rana TM
    J Biol Chem; 2000 Nov; 275(44):34314-9. PubMed ID: 10944537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin T1 stabilizes expression levels of HIV-1 Tat in cells.
    Imai K; Asamitsu K; Victoriano AF; Cueno ME; Fujinaga K; Okamoto T
    FEBS J; 2009 Dec; 276(23):7124-33. PubMed ID: 20064163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101.
    Wang X; Yamataka K; Okamoto M; Ikeda S; Baba M
    Antivir Chem Chemother; 2007; 18(4):201-11. PubMed ID: 17907378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecules targeted to a non-catalytic "RVxF" binding site of protein phosphatase-1 inhibit HIV-1.
    Ammosova T; Platonov M; Yedavalli VR; Obukhov Y; Gordeuk VR; Jeang KT; Kovalskyy D; Nekhai S
    PLoS One; 2012; 7(6):e39481. PubMed ID: 22768081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
    Liou LY; Herrmann CH; Rice AP
    J Virol; 2002 Nov; 76(21):10579-87. PubMed ID: 12368300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of human cyclin T1 N-terminal region for human immunodeficiency virus-1 Tat transcriptional activation.
    Asamitsu K; Hibi Y; Imai K; Victoriano AF; Kurimoto E; Kato K; Okamoto T
    J Mol Biol; 2011 Jul; 410(5):887-95. PubMed ID: 21763494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    J Virol; 1999 Jul; 73(7):5777-86. PubMed ID: 10364329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription.
    Ivanov A; Lin X; Ammosova T; Ilatovskiy AV; Kumari N; Lassiter H; Afangbedji N; Niu X; Petukhov MG; Nekhai S
    Retrovirology; 2018 May; 15(1):39. PubMed ID: 29792216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat.
    Jadlowsky JK; Nojima M; Schulte A; Geyer M; Okamoto T; Fujinaga K
    Retrovirology; 2008 Jul; 5():63. PubMed ID: 18620576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.
    Mousseau G; Clementz MA; Bakeman WN; Nagarsheth N; Cameron M; Shi J; Baran P; Fromentin R; Chomont N; Valente ST
    Cell Host Microbe; 2012 Jul; 12(1):97-108. PubMed ID: 22817991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter.
    Kim HY; Choi BS; Kim SS; Roh TY; Park J; Yoon CH
    Retrovirology; 2014 Aug; 11():67. PubMed ID: 25116364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of HIV-1 gene expression and transcription.
    Baba M
    Curr Top Med Chem; 2004; 4(9):871-82. PubMed ID: 15134546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
    Isel C; Karn J
    J Mol Biol; 1999 Jul; 290(5):929-41. PubMed ID: 10438593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.